Our impact on healthcare
Our technology
Dr. Shubhita Tripathi
PhD (Microbiology & Immunology), NUS Singapore
Co-Founder & CEO
Dr. Arjun Ramaswami Palaniappan
PhD (Electrical & Electronic Engineering), NTU Singapore
Co-Founder & CTO
Our technology combines the power of our unique biomarkers and state-of-the-art electronics to precisely identify multiple pathogens from a single test. A single cartridge can identify multiple pathogens from patient samples within 60 minutes at a lower cost and lower time compared with other commercially available nucleic acid tests (NAT). No specialized training is required to perform the tests.
Meet the founders
Supported by the best
50X faster and 10X cheaper point-of-care rapid diagnostic device for early detection of infectious diseases
Rapidly detect pathogens from patients samples within 1 hour as opposed to conventional culture methods that takes 2 to 14 days and NAT techniques that takes 3 to 5 hours.
Proprietary Biomarkers
Our proprietary biomarkers achieve high sensitivity and specificity without the need for amplification
50X Faster Time to Results
50X faster than culture techniques. Our device can precisely identify pathogens present in sample and can provide data on severity of infection
No Specialized Manpower
No specialized manpower is required to perform tests. Can be used by any healthcare staff
Portable
Our device is portable and can be used in any healthcare setting like hospitals, diagnostic labs, ICUs, remote locations and clinics
10X Cheaper
The cost per test is 10X cheaper than NAT tests. 10X reduction in operating costs.
10X reduction in device cost
